Scilex Holding Company Forms Partnership with Biconomy.com to Develop Future Cryptocurrency Strategies and Manage Treasury Operations
Collaboration Announcement: Scilex Holding Company has signed a non-binding Memorandum of Understanding with Biconomy.com to explore cryptocurrency and treasury management strategies, including global trading services for digital assets and a treasury management strategy focused on security and compliance.
Product Development Focus: Scilex is dedicated to developing non-opioid pain management products, with existing FDA-approved products like ZTlido®, ELYXYB®, and Gloperba®, as well as several product candidates in various stages of clinical development targeting acute and chronic pain.
Trade with 70% Backtested Accuracy
Analyst Views on SCLXW
No data
About the author
SCILEX HOLDING CO - ACEA THERA TO ACQUIRE APPROXIMATELY 82% OF THE CONTINUING COMPANY AFTER CLOSURE
Company Overview: Cilex Holding Co. has a significant stake in the Go-Forward Company, owning approximately 82% of it.
Recent Developments: The ownership stake was confirmed upon the closing of a recent transaction.
SCILEX HOLDING CO - PHOENIX TO CHANGE NAME TO ACEA PHARMA, INC. AND PLANS TO DEBUT ON NASDAQ
- Company Name Change: SciLEx Holding Co. is set to be renamed as Acea Pharma, Inc.
- Upcoming Listing: The company is expected to list on the NASDAQ stock exchange.
SCILEX HOLDING CO - ACEA THERA TO DIVEST ENTIRE STAKE IN ACEA PHARMA TO PHOENIX FOR $1 BILLION IN STOCK
Acquisition Announcement: Cilex Holding Co. has announced the sale of its subsidiary, Acea, which includes 100% of the shares of Acea Pharma.
Transaction Value: The deal is valued at $1 billion, indicating a significant financial move in the pharmaceutical sector.
SCILEX HOLDING COMPANY REVEALS SUBSIDIARIES ACEA THERAPEUTICS, INC. AND ACEA PHARMA, INC. HAVE SIGNED A DEFINITIVE AGREEMENT WITH PHOENIX ASIA HOLDINGS LIMITED
Announcement of Agreement: SciLEx Holding Company has announced a definitive agreement with Phoenix Asia Holdings Limited.
Subsidiaries Involved: The agreement involves SciLEx's subsidiaries, Acea Therapeutics, Inc. and Acea Pharma, Inc.
SCILEX HOLDING CO PLANS TO LAUNCH DREAM BOWL TOKENS ON BICONOMY EXCHANGE
- Company Announcement: Cilex Holding Co. intends to list Dream Bowl tokens on the Biconomy exchange.
- Market Impact: This move is expected to enhance the visibility and trading opportunities for Dream Bowl tokens in the cryptocurrency market.
SCILEX HOLDING COMPANY DECLARES DIVIDEND OF DREAM BOWL I MEME COIN TOKENS FOR COMMON STOCKHOLDERS AND OTHER QUALIFIED EQUITY SECURITY HOLDERS, RECORD DATE SET FOR APRIL 30, 2026
- Dividend Announcement: Cilex Holding Company has announced a dividend of Dream Bowl Lime Meme Coin to holders of common stock and other eligible equity securities.
- Record Date: The record date for this dividend distribution is set for April 30, 2026.
SCILEX HOLDING CO - ACEA THERA TO ACQUIRE APPROXIMATELY 82% OF THE CONTINUING COMPANY AFTER CLOSURE
Company Overview: Cilex Holding Co. has a significant stake in the Go-Forward Company, owning approximately 82% of it.
Recent Developments: The ownership stake was confirmed upon the closing of a recent transaction.
SCILEX HOLDING CO - PHOENIX TO CHANGE NAME TO ACEA PHARMA, INC. AND PLANS TO DEBUT ON NASDAQ
- Company Name Change: SciLEx Holding Co. is set to be renamed as Acea Pharma, Inc.
- Upcoming Listing: The company is expected to list on the NASDAQ stock exchange.
SCILEX HOLDING CO - ACEA THERA TO DIVEST ENTIRE STAKE IN ACEA PHARMA TO PHOENIX FOR $1 BILLION IN STOCK
Acquisition Announcement: Cilex Holding Co. has announced the sale of its subsidiary, Acea, which includes 100% of the shares of Acea Pharma.
Transaction Value: The deal is valued at $1 billion, indicating a significant financial move in the pharmaceutical sector.
SCILEX HOLDING COMPANY REVEALS SUBSIDIARIES ACEA THERAPEUTICS, INC. AND ACEA PHARMA, INC. HAVE SIGNED A DEFINITIVE AGREEMENT WITH PHOENIX ASIA HOLDINGS LIMITED
Announcement of Agreement: SciLEx Holding Company has announced a definitive agreement with Phoenix Asia Holdings Limited.
Subsidiaries Involved: The agreement involves SciLEx's subsidiaries, Acea Therapeutics, Inc. and Acea Pharma, Inc.
SCILEX HOLDING CO PLANS TO LAUNCH DREAM BOWL TOKENS ON BICONOMY EXCHANGE
- Company Announcement: Cilex Holding Co. intends to list Dream Bowl tokens on the Biconomy exchange.
- Market Impact: This move is expected to enhance the visibility and trading opportunities for Dream Bowl tokens in the cryptocurrency market.
SCILEX HOLDING COMPANY DECLARES DIVIDEND OF DREAM BOWL I MEME COIN TOKENS FOR COMMON STOCKHOLDERS AND OTHER QUALIFIED EQUITY SECURITY HOLDERS, RECORD DATE SET FOR APRIL 30, 2026
- Dividend Announcement: Cilex Holding Company has announced a dividend of Dream Bowl Lime Meme Coin to holders of common stock and other eligible equity securities.
- Record Date: The record date for this dividend distribution is set for April 30, 2026.
